ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
2.010
+0.020 (0.99%)
Aug 14, 2025, 1:58 PM - Market open

ImmunoPrecise Antibodies Cash Flow Statement

Millions CAD. Fiscal year is May - Apr.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 2016 - 2020
Net Income
-30.23-26.12-26.56-16.71-7.34
Upgrade
Depreciation & Amortization
5.075.56.693.772.06
Upgrade
Other Amortization
0.050.24--1.66
Upgrade
Asset Writedown & Restructuring Costs
21.1815.032.460.17-
Upgrade
Loss (Gain) From Sale of Investments
-0.01-0-0.04-0.04-
Upgrade
Stock-Based Compensation
0.451.541.943.082.75
Upgrade
Other Operating Activities
-3.3-1.74-1.04-0.771.3
Upgrade
Change in Accounts Receivable
-0.55-0.24-0.540.25-0.05
Upgrade
Change in Inventory
0.14-0.1-0.19-0.5-0.32
Upgrade
Change in Accounts Payable
0.830.98-1.671.460.88
Upgrade
Change in Unearned Revenue
-0.30.37-0.08-0.01-0.25
Upgrade
Change in Other Net Operating Assets
0.271.36-0.81-0.62-1.28
Upgrade
Operating Cash Flow
-6.41-3.18-19.83-9.92-0.6
Upgrade
Capital Expenditures
-0.8-1.4-1.5-1.07-1.43
Upgrade
Cash Acquisitions
--0.15-0.59-3.69-1.03
Upgrade
Sale (Purchase) of Intangibles
----0.19-
Upgrade
Investment in Securities
-0.120.08--
Upgrade
Other Investing Activities
--0.140.04-0.26-
Upgrade
Investing Cash Flow
-0.8-1.56-1.97-5.21-2.46
Upgrade
Short-Term Debt Issued
4.24----
Upgrade
Long-Term Debt Issued
----2.2
Upgrade
Total Debt Issued
4.24---2.2
Upgrade
Long-Term Debt Repaid
-1.58-1.34-1.34-0.96-2.97
Upgrade
Net Debt Issued (Repaid)
2.67-1.34-1.34-0.96-0.77
Upgrade
Issuance of Common Stock
12.232.360.723.8544.15
Upgrade
Other Financing Activities
----0.01-
Upgrade
Financing Cash Flow
14.891.02-0.622.8843.38
Upgrade
Foreign Exchange Rate Adjustments
-0.44-1.10.740.46-1.18
Upgrade
Net Cash Flow
7.25-4.82-21.68-11.7939.15
Upgrade
Free Cash Flow
-7.21-4.58-21.33-10.99-2.03
Upgrade
Free Cash Flow Margin
-29.40%-18.68%-103.21%-56.74%-11.32%
Upgrade
Free Cash Flow Per Share
-0.22-0.18-0.86-0.56-0.12
Upgrade
Cash Interest Paid
--0.260.040.12
Upgrade
Cash Income Tax Paid
0-0.591.191.1
Upgrade
Levered Free Cash Flow
-2.61-0.71-11.8-3.42-1.5
Upgrade
Unlevered Free Cash Flow
-2.43-0.69-11.78-3.37-1.1
Upgrade
Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q